G1 arrest of U937 cells by onconase is associated with suppression of cyclin D3 expression, induction of p16INK4A, p21WAF1/CIP1 and p27KIP and decreased pRb phosphorylation

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Leukemia

• Publication date

  1998-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2401100PMID 9697879
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phosphorylation of retinoblastoma susceptibility gene protein assayed in individual lymphocytes during their mitogenic stimulation.

  1998cited by this paper
• Acute leukemia: Mechanisms of cell survival as targets for therapy (review)

  1997cited by this paper
• Cyclin-dependent kinase inhibitors: the age of crystals.

  1997cited by this paper
• Nuclear association of cyclin D1 in human fibroblasts: tight binding to nuclear structures and modulation by protein kinase inhibitors.

  1997cited by this paper
• The retinoblastoma protein pathway in cell cycle control and cancer.

  1997cited by this paper
• Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis).

  1997cited by this paper
• Correlation between DNA replication and expression of cyclins A and B1 in individual MOLT-4 cells.

  1997cited by this paper
• Acute leukemia.

  1997cited by this paper
• Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.

  1996cited by this paper
• The NF-kappa B and I kappa B proteins: new discoveries and insights.

  1996cited by this paper
• Retinoblastoma protein family in cell cycle and cancer: A review

  1996cited by this paper
• Cytometry of cyclin proteins.

  1996cited by this paper
• Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

  1996cited by this paper
• Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

  1996cited by this paper
• Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

  1996cited by this paper
• Detection of apoptosis and DNA replication by differential labeling of DNA strand breaks with fluorochromes of different color.

  1996cited by this paper
• Mutations of the p16 gene in gliomas.

  1996cited by this paper
• Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

  1996cited by this paper
• Unscheduled expression of cyclins D1 and D3 in human tumour cell lines

  1996cited by this paper
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights

  1996cited by this paper
• Cell Growth Arrest and Induction of Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Mediated by STAT1

  1996cited by this paper
• Effect of protease inhibitors on early events of apoptosis.

  1996cited by this paper
• Suppression of TNF-α-Induced Apoptosis by NF-κB

  1996cited by this paper
• Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

  1995cited by this paper
• Principles of CDK regulation

  1995cited by this paper
• Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA

  1995cited by this paper
• Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.

  1995cited by this paper
• Relationship between response rate and median survival in patients with advanced nonsmall cell lung-cancer - comparison of onconase(r) with other anticancer agents.

  1995cited by this paper
• Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism.

  1995cited by this paper
• Dissociation of nuclear and cytoplasmic cell cycle progression by drugs employed in cell synchronization.

  1995cited by this paper
• p16INK4A and p15INK4B gene deletions in primary leukemias.

  1995cited by this paper
• Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.

  1995cited by this paper
• Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

  1995cited by this paper
• Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.

  1995cited by this paper
• Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.

  1995cited by this paper
• A Study of the Intracellular Routing of Cytotoxic Ribonucleases (*)

  1995cited by this paper
• Growth imbalance and altered expression of cyclins B1, A, E, and D3 in MOLT-4 cells synchronized in the cell cycle by inhibitors of DNA replication.

  1995cited by this paper
• Cyclin‐dependent protein kinases: Key regulators of the eukaryotic cell cycle

  1995cited by this paper
• p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein.

  1994cited by this paper
• Activation of the E2F transcription factor by cyclin D1 is blocked by p16INK4, the product of the putative tumor suppressor gene MTS1.

  1994cited by this paper
• STRUCTURE, REGULATION AND FUNCTION OF NF-1d3

  1994cited by this paper
• p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

  1994cited by this paper
• Mutations and altered expression of p16INK4 in human cancer.

  1994cited by this paper
• DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

  1994cited by this paper
• Refined 1.7 A X-ray crystallographic structure of P-30 protein, an amphibian ribonuclease with anti-tumor activity.

  1994cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

  1994cited by this paper
• The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest.

  1994cited by this paper
• Analysis of DNA content and cyclin protein expression in studies of DNA ploidy, growth fraction, lymphocyte stimulation, and the cell cycle.

  1994cited by this paper
• Expression of G1 and G2 cyclins measured in individual cells by multiparameter flow cytometry: a new tool in the analysis of the cell cycle

  1994cited by this paper
• A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor beta-arrested epithelial cells

  1994cited by this paper
• Structure, regulation and function of NF-kappa B.

  1994cited by this paper
• Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes.

  1993cited by this paper
• A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.

  1993cited by this paper
• Physical interaction of the retinoblastoma protein with human D cyclins.

  1993cited by this paper
• p21 is a universal inhibitor of cyclin kinases

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Cytotoxic Onconase and Ribonuclease A Chimeras: Comparison and in Vitro Characterization

  1993cited by this paper
• Invitro synergism between a novel amphibian oocytic ribonuclease (onconase(r)) and tamoxifen, lovastatin and Cisplatin, in human ovcar-3 ovarian-carcinoma cell-line.

  1992cited by this paper
• Synergism between a novel amphibian oocyte ribonuclease and lovastatin in inducing cytostatic and cytotoxic effects in human lung and pancreatic carcinoma cell lines.

  1992cited by this paper
• Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases.

  1991cited by this paper
• Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos.

  1990cited by this paper
• Tamoxifen and trifluoroperazine (Stelazine) potentiate cytostatic/cytotoxic effects of P‐30 protein, a novel protein possessing anti‐tumour activity

  1990cited by this paper
• Cytostatic and Cytotoxic Effects of Pannon (P‐30 Protein), A Novel Anticancer Agent

  1988cited by this paper
• Mutations and altered expression of p 16 INK 4 in human cancer ( p 53 protein / tumor-suppressor gene / cyclin Di / retinoblastoma protein )

  year unknowncited by this paper

• Role of DEAD/DEAH-box helicases in immunity, infection and cancers

  2025cites this paper
• Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections

  2022cites this paper
• Upregulation of miR-34a-5p, miR-20a-3p and miR-29a-3p by Onconase in A375 Melanoma Cells Correlates with the Downregulation of Specific Onco-Proteins

  2022cites this paper
• Strengths and Challenges of Secretory Ribonucleases as AntiTumor Agents

  2021cites this paper
• DEAD-Box RNA Helicases in Cell Cycle Control and Clinical Therapy

  2021influential citation
• Antiviral Ranpirnase TMR-001 Inhibits Rabies Virus Release and Cell-to-Cell Infection In Vitro

  2020cites this paper
• Activating transcription factor 3 is crucial for antitumor activity and to strengthen the antiviral properties of Onconase

  2016cites this paper
• RNase activity of sialic acid-binding lectin from bullfrog eggs drives antitumor effect via the activation of p38 MAPK to caspase-3/7 signaling pathway in human breast cancer cells

  2016cites this paper
• Ribonucleases with Antiproliferative Properties: Molecular Biological and Biochemical Characteristics

  2016cites this paper
• Combination of onconase and dihydroartemisinin synergistically suppresses growth and angiogenesis of non-small-cell lung carcinoma and malignant mesothelioma.

  2016cites this paper
• Ферментные препараты в онкогематологии: актуальные направления экспериментальных исследований и перспективы клинического применения

  2014cites this paper
• Investigating the effects of double mutation C30A/C75A on onconase structure: Studies at atomic resolution

  2014cites this paper
• 22. ImmunoRNase Fusions

  2013cites this paper
• Gutschner T , Diederichs S . The hallmarks of cancer : a long non-coding RNA point of view . RNA Biol 9 : 703-719

  2012cites this paper
• Ribonucleases as Novel Chemotherapeutics

  2012cites this paper
• Onconase downregulates microRNA expression through targeting microRNA precursors

  2012cites this paper
• The hallmarks of cancer

  2012cites this paper
• Linkage of the potent leukemogenic activity of Meis1 to cell-cycle entry and transcriptional regulation of cyclin D3.

  2010cites this paper
• A human pancreatic ribonuclease variant kills cancer cells by apoptosis and reduces the expression of P-glycoprotein in MDR cell lines

  2010influential citation
• [Onconase: a ribonuclease with antitumor activity].

  2010cites this paper
• Ribonucleases and immunoRNases as anticancer drugs.

  2009cites this paper
• Effect of Onconase on double-stranded RNA in vitro.

  2009cites this paper
• Ribonucleases as potential modalities in anticancer therapy.

  2009cites this paper
• Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.

  2008cites this paper
• Ribonucleases as novel chemotherapeutics : the ranpirnase example.

  2008cites this paper
• The influence of curcumin on the cell cycle of Hl-60 cells- and contrast study

  2008cites this paper
• A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells

  2008cites this paper
• Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines

  2008cites this paper
• Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma

  2008cites this paper
• A novel biological actions acquired by ribonuclease through oligomerization.

  2008cites this paper
• Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.

  2008cites this paper
• The therapeutic potential of the novel ribonuclease ranpirnase (Onconase®) in the treatment of malignant mesothelioma

  2008cites this paper
• The experimental and clinical study on the effect of curcumin on cell cycle proteins and regulating proteins of apoptosis in acute myelogenous leukemia

  2008cites this paper
• The cytotoxic ribonuclease onconase targets RNA interference (siRNA)

  2008cites this paper
• Heme oxygenase -1 gene therapy: recent advances and therapeutic applications.

  2007cites this paper
• Cytostatic and Cytotoxic Properties of Amphinase: A Novel Cytotoxic Ribonuclease from Rana pipiens Oocytes

  2007cites this paper
• Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.

  2007cites this paper
• The interdependence between catalytic activity, Conformational stability and cytotoxicity of onconase

  2007cites this paper
• Mild hyperthermia predisposes tumor cells to undergo apoptosis upon treatment with onconase.

  2007cites this paper
• Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress.

  2007cites this paper
• Roles of N-terminal pyroglutamate in maintaining structural integrity and pKa values of catalytic histidine residues in bullfrog ribonuclease 3.

  2006cites this paper
• Contribution of structural peculiarities of onconase to its high stability and folding kinetics.

  2006cites this paper
• Ribonucleases as a Novel Pro-Apoptotic Anticancer Strategy: Review of the Preclinical and Clinical Data for Ranpirnase

  2005cites this paper
• Why ribonucleases induce tumor cell death

  2005cites this paper
• Serial Review: Heme Oxygenase in Human Disease Serial Review Editor: Phyllis A. Dennery Heme oxygenase and the cardiovascular-renal system i

  2005cites this paper
• On the track of antitumour ribonucleases.

  2005cites this paper
• Heme oxygenase and the cardiovascular-renal system.

  2005cites this paper
• Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.

  2004cites this paper
• Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin

  2004cites this paper
• Oligomerization of bovine ribonuclease A: structural and functional features of its multimers.

  2004cites this paper
• Mechanism of antitumor drug action assessed by cytometry.

  2004cites this paper
• Ribonuclease inhibitor as an intracellular sentry.

  2003cites this paper
• ONCONASE® and Its Therapeutic Potential

  2003cites this paper
• Solution structure of the cytotoxic RNase 4 from oocytes of bullfrog Rana catesbeiana.

  2003cites this paper
• Cytotoxic Ribonucleases and RNA Interference (RNAi)

  2003cites this paper
• Effects of resveratrol on the G0-G1 transition and cell cycle progression of mitogenically stimulated human lymphocytes

  2002cites this paper
• Effects of resveratrol on the G(0)-G(1) transition and cell cycle progression of mitogenically stimulated human lymphocytes.

  2002cites this paper
• Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).

  2002cites this paper
• Increased Apoptosis in B-chronic Lymphocytic Leukemia Cells as a Result of Cyclin D3 Down Regulation

  2002cites this paper
• Role of human heme oxygenase‐1 in attenuating TNF‐α‐mediated inflammation injury in endothelial cells

  2002cites this paper
• Combined effects of onconase and IFN-beta on proliferation, macromolecular syntheses and expression of STAT-1 in JCA-1 cancer cells.

  2002cites this paper
• Activation of caspases and serine proteases during apoptosis induced by onconase (Ranpirnase).

  2002cites this paper
• TNF-alpha-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells.

  2002cites this paper
• Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.

  2002cites this paper
• TNF-α-mediated cell death is attenuated by retrovirus delivery of human heme oxygenase-1 gene into human microvessel endothelial cells

  2002cites this paper
• Cyclin E in Bladder Cancer Cycle: Disruption of the Nucleoplasm-Nucleolar Shuttling of Intranuclear Compartmentalization of Cyclin E during the Cell

  2001cites this paper
• 1H, 13C and 15N resonance assignments and secondary structure of the cytotoxic protein RNase 4 from bullfrog Rana catesbeiana oocytes.

  2001cites this paper
• Contribution of chain termini to the conformational stability and biological activity of onconase.

  2001cites this paper
• Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups.

  2001cites this paper
• 1H, 15N and 13C resonance assignments and secondary structure determination of the RC-RNase 2 from oocytes of bullfrog Rana catesbeiana.

  2001cites this paper
• Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer.

  2001cites this paper
• Cancer chemotherapy--ribonucleases to the rescue.

  2001cites this paper
• Induction of differentiation of leukaemic (HL‐60) or prostate cancer (LNCaP, JCA‐1) cells potentiates apoptosis triggered by onconase

  2000cites this paper
• Enhanced cellular radiation sensitivity of androgen-independent human prostate tumor cells by onconase.

  2000cites this paper
• Bovine seminal ribonuclease exerts selective cytotoxicity toward neuroblastoma cells both sensitive and resistant to chemotherapeutic drugs.

  2000cites this paper
• Disease association and cytotoxic effects of DNA-hydrolyzing autoantibodies.

  2000cites this paper
• Urinary proteins with pro-apoptotic and antitumor activity

  2000cites this paper
• Multiparameter analysis of progeny of individual cells by laser scanning cytometry.

  2000cites this paper
• H-, K- and N-Ras inhibit myeloid leukemia cell proliferation by a p21WAF1-dependent mechanism

  2000cites this paper
• Onconase: an unusually stable protein.

  2000cites this paper
• A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.

  1999cites this paper
• DETECTION PAR CYTOMETRIE DE FLUX DE CONFORMATIONS DE pRB DANS DES CELLULES INDIVIDUELLES

  1999cites this paper
• Effective expression and purification of recombinant onconase, an antitumor protein

  1999cites this paper
• Natural and engineered cytotoxic ribonucleases: therapeutic potential.

  1999cites this paper
• Histone H3 phosphorylation in human monocytes and during HL-60 cell differentiation.

  1999cites this paper
• Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction

  1999cites this paper
• The butler did it: search for killer(s) of Kaposi's sarcoma cells in preparations of human chorionic gonadotropin.

  1999cites this paper
• Control of Mammalian Cell Proliferation as an Important Strategy in Cell Culture Technology, Cancer Therapy and Tissue Engineering

  1999cites this paper
• Cell Engineering

  1999cites this paper
• Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor.

  1998cites this paper